sulpiride has been researched along with Adenoma, Prostatic in 11 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Specific effects of ultra-low doses of antibodies to prostate-specific antigen obtained from laboratory rats of late reproductive age with sulpiride model of benign prostatic hyperplasia were compared with the results of clinical application of the preparation." | 9.15 | Modification of sulpiride model of benign prostatic hyperplasia for evaluation of the effectiveness of drug therapy. ( Borovskaja, TG; Chemerova, JA; Fomina, TI; Jurmazov, ZA; Pahomova, AV; Poluektova, ME; Rumpel', OA; Sergeeva, SA; Udut, VV, 2011) |
| "Specific effects of ultra-low doses of antibodies to prostate-specific antigen obtained from laboratory rats of late reproductive age with sulpiride model of benign prostatic hyperplasia were compared with the results of clinical application of the preparation." | 5.15 | Modification of sulpiride model of benign prostatic hyperplasia for evaluation of the effectiveness of drug therapy. ( Borovskaja, TG; Chemerova, JA; Fomina, TI; Jurmazov, ZA; Pahomova, AV; Poluektova, ME; Rumpel', OA; Sergeeva, SA; Udut, VV, 2011) |
| "Experimental model of sulpiride-provoked benign prostatic hyperplasia was employed to comparatively assess the effect of phenolic antioxidants (dihydroquercetin, p-thyrozol, dibornol, and prostagenin) on prostate morphology." | 3.91 | Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia. ( Borovskaya, TG; Buravlev, EV; Chukicheva, IY; Dygai, AM; Fomina, TI; Goldberg, VE; Grigor'eva, VA; Kamalova, SI; Kuchin, AV; Plotnikov, MB; Poluektova, ME; Vychuzhanina, AV, 2019) |
| "Prostatotropic activity of (3,5-dimethyl-4-hydroxy)benzyl thiododecane (T-DD) was evaluated on a model of benign prostatic hyperplasia induced in Wistar rats by chronic (2 months) intraperitoneal administration of sulpiride (40 mg/kg)." | 3.91 | Morphological Assessment of Prostatotropic Activity of (3,5-Dimethyl-4-Hydroxy)Benzyl Thiododecane on a Model of Benign Prostatic Hyperplasia in Rats. ( Nizomov, SA; Prosenko, AE; Semenov, DE; Sorokina, IV; Tolstikova, TG; Zhukova, NA, 2019) |
| "A course of dihydroquercetin (antioxidant) injections to 5-month-old Wistar rats with sulpiride-induced benign prostatic hyperplasia led to reduction of proliferative activity in the glandular structures and to attenuation of the inflammatory reaction in the tissue." | 3.81 | Dihydroquercetin effects on the morphology and antioxidant/prooxidant balance of the prostate in rats with sulpiride-induced benign hyperplasia. ( Borovskaya, TG; Fomina, TI; Goldberg, VE; Grigor'eva, VA; Kamalova, SI; Krivova, NA; Plotnikov, MB; Poluektova, ME; Shchemerova, YA; Vychuzhanina, AV; Zaeva, OB, 2015) |
| "Afala (ultralow-dose antibodies to prostate-specific antigen) injected for 60 days to rats with hormone-induced prostatitis caused by sulpiride prevented the development of prostatic hyperplasia and reduced the severity of histological changes." | 3.74 | Comparative study of pharmacological activity of afala on the model of hormone-induced prostatitis in rats. ( Borovskaya, TG; Dugina, JL; Epstein, OI; Kheyfets, IA; Savelieva, KV; Sergeeva, SA, 2007) |
| " To enhance PRL release, we induced hyperprolactinemia by administering chronic injections of sulpiride (40 mg." | 3.71 | Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence. ( Ahidouch, A; Authie, D; Beauvillain, JC; Carpentier, F; Cousse, H; Croix, D; Dewailly, E; Dupouy, JP; Fournier, S; Le Bourhis, X; Legrand, G; Prevarskaya, N; Raynaud, JP; Slomianny, C; Van Coppenolle, F, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Borovskaya, TG | 4 |
| Kamalova, SI | 2 |
| Grigor'eva, VA | 2 |
| Poluektova, ME | 4 |
| Vychuzhanina, AV | 3 |
| Kuchin, AV | 1 |
| Chukicheva, IY | 1 |
| Buravlev, EV | 1 |
| Fomina, TI | 4 |
| Plotnikov, MB | 2 |
| Goldberg, VE | 2 |
| Dygai, AM | 1 |
| Nizomov, SA | 1 |
| Sorokina, IV | 1 |
| Zhukova, NA | 1 |
| Tolstikova, TG | 1 |
| Semenov, DE | 1 |
| Prosenko, AE | 1 |
| Tsvetkov, IS | 1 |
| Kosyreva, AM | 1 |
| Mkhitarov, VA | 1 |
| Postovalova, EA | 1 |
| Khochanskiy, DN | 1 |
| Makarova, OV | 1 |
| Bredova, OY | 1 |
| Ostrov, VF | 1 |
| Ermolaeva, LA | 1 |
| Pakhomova, AV | 1 |
| Shchemerova, YA | 2 |
| Krivova, NA | 1 |
| Zaeva, OB | 1 |
| Lesovaya, EA | 1 |
| Kirsanov, KI | 1 |
| Antoshina, EE | 1 |
| Trukhanova, LS | 1 |
| Gorkova, TG | 1 |
| Shipaeva, EV | 1 |
| Salimov, RM | 1 |
| Belitsky, GA | 1 |
| Blagosklonny, MV | 1 |
| Yakubovskaya, MG | 1 |
| Chernova, OB | 1 |
| Savelieva, KV | 1 |
| Kheyfets, IA | 1 |
| Dugina, JL | 1 |
| Sergeeva, SA | 2 |
| Epstein, OI | 1 |
| Borovskaja, TG | 1 |
| Udut, VV | 1 |
| Jurmazov, ZA | 1 |
| Pahomova, AV | 1 |
| Chemerova, JA | 1 |
| Rumpel', OA | 1 |
| Belostotskaya, LI | 1 |
| Gomon, ON | 1 |
| Nikitchenko, YV | 1 |
| Chaika, LA | 1 |
| Bondar, VV | 1 |
| Dzyuba, VN | 1 |
| Van Coppenolle, F | 1 |
| Slomianny, C | 1 |
| Carpentier, F | 1 |
| Le Bourhis, X | 1 |
| Ahidouch, A | 1 |
| Croix, D | 1 |
| Legrand, G | 1 |
| Dewailly, E | 1 |
| Fournier, S | 1 |
| Cousse, H | 1 |
| Authie, D | 1 |
| Raynaud, JP | 1 |
| Beauvillain, JC | 1 |
| Dupouy, JP | 1 |
| Prevarskaya, N | 1 |
| Mongioi, A | 1 |
| Vicari, E | 1 |
| D'Agata, R | 1 |
1 trial available for sulpiride and Adenoma, Prostatic
| Article | Year |
|---|---|
Modification of sulpiride model of benign prostatic hyperplasia for evaluation of the effectiveness of drug therapy.
Topics: Animals; Antibodies; Disease Models, Animal; Drug Screening Assays, Antitumor; Humans; Male; Middle | 2011 |
10 other studies available for sulpiride and Adenoma, Prostatic
| Article | Year |
|---|---|
Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia.
Topics: Acinar Cells; Animals; Animals, Outbred Strains; Anti-Inflammatory Agents; Antioxidants; Disease Mod | 2019 |
Morphological Assessment of Prostatotropic Activity of (3,5-Dimethyl-4-Hydroxy)Benzyl Thiododecane on a Model of Benign Prostatic Hyperplasia in Rats.
Topics: Animals; Disease Models, Animal; Down-Regulation; Male; Organ Size; Plant Extracts; Prostate; Prosta | 2019 |
Morphological and Biochemical Characteristics of Prostate Hyperplasia during Sulpiride Treatment.
Topics: Acinar Cells; Animals; Disease Models, Animal; Dopamine Antagonists; Epithelial Cells; Gene Expressi | 2020 |
Comparative evaluation of the efficiency of prostatotropic agents of natural origin in experimental benign prostatic hyperplasia.
Topics: Animals; Cattle; Male; Peptides; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats | 2013 |
Dihydroquercetin effects on the morphology and antioxidant/prooxidant balance of the prostate in rats with sulpiride-induced benign hyperplasia.
Topics: Animals; Antioxidants; Histological Techniques; Male; Prostatic Hyperplasia; Quercetin; Rats; Rats, | 2015 |
Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Disease Models, Animal; Drug Administration Schedule; F | 2015 |
Comparative study of pharmacological activity of afala on the model of hormone-induced prostatitis in rats.
Topics: Animals; Antibodies; Disease Models, Animal; Immunoenzyme Techniques; Male; Organ Size; Plant Extrac | 2007 |
Prooxidant-antioxidant balance in the prostate and blood of rats with sulpyride[corrected]-induced prostatic hyperplasia corrected with prostatilen.
Topics: Animals; Glutathione Peroxidase; Lipid Peroxides; Male; Oxidation-Reduction; Peptides; Prostatic Hyp | 2005 |
Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence.
Topics: Animals; Apoptosis; Chronic Disease; Dihydrotestosterone; Dopamine Antagonists; Gonadal Steroid Horm | 2001 |
The prolactin-secreting system in relation to aging.
Topics: Aged; Aging; Humans; Male; Middle Aged; Prolactin; Prostatic Hyperplasia; Reference Values; Sulpirid | 1985 |